{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:35Z","timestamp":1760189615571,"version":"3.40.4"},"reference-count":13,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,4,27]]},"abstract":"<jats:p>A female patient with consanguineous parents presented at the age of 4 with isolated hypoparathyroidism due to a parathyroid hormone (PTH) gene mutation. She was managed with alfacalcidol and calcium supplements, and developed normally. Her consanguineous parents described symptoms suggestive of hypocalcaemia but had normal serum calcium and low normal PTH levels. A molecular diagnosis obtained in her adulthood revealed the presence of homozygous point mutation (c.68C&gt;A) in exon 2 introducing a premature stop codon resulting in a non-functional precursor protein. This mutation has been reported only once before. Our patient remained on stable doses of alfacalcidol during pregnancy, but stopped all supplementation while breast feeding. This case confirms that alternative mechanisms (likely breast-derived parathyroid hormone-related protein) contribute to calcium homeostasis during breast feeding. Heterozygotes for the c.68C&gt;A\u2009mutation may have latent hypoparathyroidism and maintain calcium homeostasis except during prolonged hypocalcaemia. This would suggest incomplete dominance, or a dose effect of the wild-type PTH allele.<\/jats:p>","DOI":"10.1136\/bcr-2017-223811","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T12:29:32Z","timestamp":1527337772000},"page":"bcr-2017-223811","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Successful pregnancies and reduced treatment requirement while breast feeding in a patient with congenital hypoparathyroidism due to homozygous c.68C&gt;A null parathyroid hormone gene mutation"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5648-680X","authenticated-orcid":false,"given":"Joanne","family":"Dixon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,5,26]]},"reference":[{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00435-0"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1029"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.3","doi-asserted-by":"crossref","unstructured":"Jameson J , De Groot L . Parathyroid hormone and parathyroid hormone-related peptide in the regulation of calcium homeostatsis and bone development. In: Endocrinology adult and pediatric. 6th edn, 2010:1040\u201373.","DOI":"10.1016\/B978-1-4160-5583-9.00056-3"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114811"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.10.3792"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.6","doi-asserted-by":"publisher","DOI":"10.1038\/ng0592-149"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2532","article-title":"A Homozygous [Cys25]PTH(1-84) mutation that impairs PTH\/PTHrP receptor activation defines a novel form of hypoparathyroidism","volume":"30","author":"Lee","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.8","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/jc.2017-00250","article-title":"Autosomal dominant PTH gene signal sequence mutation in a family with familial isolated hypoparathyroidism","volume":"102","author":"Cinque","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2012.06.009","article-title":"A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism","volume":"51","author":"Ertl","year":"2012","journal-title":"Bone"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.10","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM198812153192407","article-title":"Unmasking of hypoparathyroidism in familial partial DiGeorge syndrome by challenge with disodium edetate","volume":"319","author":"Gidding","year":"1988","journal-title":"N Engl J Med"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.11","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390284"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.07.001"},{"key":"2025042703422793000_2018.may25_1.bcr-2017-223811.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2011.08.002"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-223811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:42:35Z","timestamp":1745750555000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-223811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,26]]},"references-count":13,"alternative-id":["10.1136\/bcr-2017-223811"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-223811","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,5,26]]}}}